Navigation Links
Wockhardt acquires Protinex, Farex brands from Netherland Co

Indian drug maker, Wockhardt Ltd today said it has acquired Dumex India Pvt Ltd along with its two products Protinex and Farex// from the Netherlands-based Royal Numico NV for an undisclosed sum.

The company plans to change the acquired company's name to 'Dumex' within six months, Wockhardt informed the Bombay stock Exchange.

"Acquisition of Protinex and Farex is a critical milestone in our growth plans in nutrition business. Today's acquisition makes us the undisputed leader in medical nutrition. The global market for medical nutrition is worth USD 32.5 billion," Wockhardt Chairman Habil Khorakiwala said.

Under the agreement, Royal Numico would also offer technical know-how to the company for the manufacture of specialised sugar-free infant food products currently marketed in India and internationally, under its brand names Dulac and Dupro.

The acquisition has the potential to double its nutrition products sale to Rs 120 crore as Protinex and Farex complements its product range, it added.

The company would inherit a strong sales and marketing organisation with 235 personnel and the acquisition follows Royal Numico's decision to focus on China and other markets.

The company has a strong presence in infant nutrition with Dexolac, Nusobee and Firstfood brands, with annual sales of ab out Rs 60 crore.

The company is also in talks with global companies for in-licen sing medical nutrition products.
'"/>




Page: 1

Related medicine news :

1. Wockhardt Group Plans Hospital In Delhi By End-2007
2. Biovac, Hepatitis A Vaccine Marketed By Wockhardt
3. Indias Wockhardt Acquires Irish Firm
4. Mercy killing for newborn with incurable disease in Netherlands
5. Netherlands to lift livestock restrictions over avian influenza

Post Your Comments:
(Date:11/26/2009)...ch Triangle Dental (RTDental), a leading dental gr...unced the expansion of its services to include LUM...acmillan. , Durham, NC... announce that Dr. Doug Macmillan, an experienced ...nal advanced training seminar. RTDental’s a...
(Date:11/25/2009)...Newswire/--TheBartleHallConventionCenterwilltempor...10,whenKansasCityhoststhelatestinaseriesofmassivef...ceventhasthepotentialtobethebiggestoneyet,becausei...eekdaysinsteadofoveraweekend,"SheriWood,executived...oftheNationalAssociationofFreeClinics(NAFC). ,,...
(Date:11/25/2009)...PRNewswire/--Thanksgivingmealswillbedeliveredtoapp...chareathankstoFaithInAction/VolunteerActionforAgin...ionofSCANHealthPlan.Formorethan17yearstheseorganiz...mThanksgivingmealstoseniorsinneedinLongBeach,Lakew...ingcities. ,, "Ourwarmholidaymealsaredeliveredt...
(Date:11/25/2009)...nts,Business,andPressJoinEfforttoEducate ,, ME...in,theNationalBipolarFoundationandtheMedicAlertFou...Stable"program,whichisnowbeingwidelyacceptedasapre...heNationalBipolarFoundationreceivedaproclamationof...GovernorofLouisianaMitchLandrieu.TheNationalBipola...
(Date:11/25/2009)...ssure? This simple question has been the focus of...ted gene Modulates High Blood Pressure in Mice & M...mple question has been the focus of intense resear...irst time established a link between a novel gene,...ess in mice as well as humans. The studies were di...
Breaking Medicine News(10 mins):Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:New stress-related gene modulates high blood pressure in mice and men 2
...RVINE, Calif., Oct. 9 Spectrum,Pharmaceuticals, I... present,an overview of the Company on Wednesday, ... Investor Forum, being held at the Palace Hotel in... at, http://www.spectrumpharm.com . Replays will b...
... ATLANTA, October 7, 2007 -- Two of the three scie...gy or Medicine received funding from the American ... 42 the number of Nobel Laureates among the Societ...olina are co-winners along with Sir Martin J. Evan...
...ATSONVILLE, Calif., Oct. 9 In light of last week,...nsumption of seafood for,pregnant women and the an...ecommending pregnant/lactating women consume at le...vate health,organizations as well as government ag...
...kahau RTLS Centralizes Asset Management and Enable...es in North Carolina, RESTON, Virginia, October 9...eal Time Location Systems (RTLS), today announced,... States. CHS is using the Ekahau RTLS solution for...
...ips from the American Heart Association, DALLAS, ...aveling, the holidays can play havoc with a health...tools and tips to ensure that,positive health habi...ion,s worksite wellness campaign, by going to "MyS...
...ONDON, Oct. 9 Chiltern, a leading global clinical...ent of Steve Albrecht to,the role of Director, Bus...s over 20 years of CRO industry experience to his ...ht will be providing leadership for the developmen...
Other Medicine News:Health News:Spectrum Pharmaceuticals to Present at the Biotechnology Industry Organization Investor Forum 2Health News:Purified Fish Oil Concentrates Offer Solution to Current Seafood Controversy for Pregnant and Breastfeeding Women! 2Health News:Carolinas HealthCare Selects Ekahau for One of Nation's Largest Healthcare System RTLS Deployments 2Health News:Carolinas HealthCare Selects Ekahau for One of Nation's Largest Healthcare System RTLS Deployments 3Health News:Carolinas HealthCare Selects Ekahau for One of Nation's Largest Healthcare System RTLS Deployments 4Health News:Have a Heart-Healthy Holiday 2Health News:Chiltern Appoints Steve Albrecht to Support Further Expansion in Late Phase 2
(Date:11/24/2009)...,, PITTSBURGH,Nov.24/PRNewswire/-- ,, WHA...23yearsfollowinganautoaccident,wasactuallyfullycon...dMorningAmericasegment.TheDynaVoxEyeMaxwasfeatured...romeandotherconditionscanunlockcommunication. ,...ilableonlineat www.dynavoxtech.com ,, WH...
(Date:11/24/2009)...,, SANDIEGO,Nov.24/PRNewswire-FirstCall/--An...daythatitwillpresentatthe21stAnnualPiperJaffrayHea....EST(6:00a.m.PST).TheconferenceisbeingheldatTheNew...efExecutiveOfficerofAnadys,willprovideanoverviewof...NA773. ,, Thecorporatepresentationwillbesimulta...
(Date:11/24/2009)...,, SANDIEGO,Nov.24/PRNewswire/--Accumetrics,...yNow®System,thefirstrapidandeasy-to-usediagno...ipleantiplateletagents(e.g.Plavix®andaspirin)...fAccumetrics,andGregoryJ.Tibbitts,ChiefFinancialOf...iewatthe21stAnnualPiperJaffrayHealthCareConference...
Breaking Medicine Technology:DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Accumetrics to Present at the 21st Annual Piper Jaffray Health Care Conference 280 Million European Runners Reveal Their Reasons to Run 55673 180 Million European Runners Reveal Their Reasons to Run 55673 280 Million European Runners Reveal Their Reasons to Run 55673 3Flu Shots Now Available for 2009 Seasonal Influenza at MD Now Urgent Care Centers in Palm Beach County Florida 55670 1Flu Shots Now Available for 2009 Seasonal Influenza at MD Now Urgent Care Centers in Palm Beach County Florida 55670 2Flu Shots Now Available for 2009 Seasonal Influenza at MD Now Urgent Care Centers in Palm Beach County Florida 55670 3Flu Shots Now Available for 2009 Seasonal Influenza at MD Now Urgent Care Centers in Palm Beach County Florida 55670 4Tarascon Publishing Presents Essential Translation Resource for Healthcare Providers with Non English Speaking Patients 55667 1Tarascon Publishing Presents Essential Translation Resource for Healthcare Providers with Non English Speaking Patients 55667 2Tarascon Publishing Presents Essential Translation Resource for Healthcare Providers with Non English Speaking Patients 55667 3
...lts from Exploratory Phase IIa Clinical Trial in T...8, 2007 /PRNewswire-FirstCall/ - Transition,Therap...esults from,its exploratory Phase IIa clinical tri...h gastrin-based therapy, E1-I.N.T.(TM), showed,sus...ers, including,haemoglobinA1C (HbA1c), for 6 month...
...ON, June 28, 2007 /PRNewswire/ - Cytochroma Inc.,a...al trial of,CTA018 Injection. The initial top-line...fe and well tolerated. Complete study,results are ...Phase I trial was an open label,placebo-controlle...ed to 20 healthy volunteers. In this trial, the sa...
Other Medicine Technology:A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 2A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 3A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 4A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 5Cytochroma Reports Positive Phase I Clinical Data for CTA018,Injection 2Cytochroma Reports Positive Phase I Clinical Data for CTA018,Injection 3
ExcaliburPlus PC, 100V, 50Hz/60Hz
ExcaliburPlus PC, 220V, 50Hz
Bipolar Coagulator
Elmed BC 50 M/M
Medicine Products: